Uncategorized

DOJ weighs in favor of pharma on 340B dispute

Published

on

Pharma is gaining ground in a yearslong struggle over access to federal drug discounts.

Drugmakers and the federal government have historically been on opposing sides of contract pharmacy policy under 340B. But …

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version